Home » Topics » Disease categories and therapies » Immune

Immune
RSS

FDA committee does not recommend approval of Prograf for GVHD

Jan. 21, 1999

Global FluMist collaboration announced by Aviron and Wyeth Lederle Vaccines

Jan. 14, 1999

Licensing opportunity from RCT: VZV subunit vaccine

Jan. 14, 1999

First vaccine for Lyme disease now available from SB in the U.S.

Jan. 13, 1999

Licensing opportunity from Peptech: anti-TNF antibodies with a range of therapeutic applications

Jan. 13, 1999

SangStat continues to progress with generic ciclosporin formulations

Jan. 12, 1999

Peptide immunomodulators available for licensing from Peptech

Jan. 12, 1999

Eisai prepares novel digalactosylceramide derivatives for multiple indications

Jan. 11, 1999

Mycophenolate mofetil potentiates antiherpesvirus activity of aciclovir

Jan. 8, 1999

FDA clears new product for preventing kidney transplant rejection

Jan. 5, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...